Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank29
3Y CAGR-16.8%
5Y CAGR+15.8%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-16.8%/yr
Annual compound
5Y CAGR
+15.8%/yr
Recent deceleration
Percentile
P29
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -14.2% |
| 2024 | 0.02 | -40.5% |
| 2023 | 0.03 | +12.7% |
| 2022 | 0.02 | +12.0% |
| 2021 | 0.02 | +223.4% |
| 2020 | 0.01 | -95.1% |
| 2019 | 0.13 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.11 | -71.2% |
| 2016 | 0.38 | - |